AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
12.63
+0.59 (4.90%)
Jul 15, 2026, 4:00 PM EDT - Market closed
AgomAb Therapeutics NV Employees
AgomAb Therapeutics NV had 62 employees as of December 31, 2025. The number of employees increased by 4 or 7.27% compared to the previous year.
Employees
62
Change (1Y)
4
Growth (1Y)
7.27%
Revenue / Employee
n/a
Profits / Employee
-$1,467,672
Market Cap
622.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 62 | 4 | 7.27% |
| Dec 31, 2024 | 58 | 24 | 70.00% |
| Dec 31, 2023 | 34 | 33 | 3,300.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Ginkgo Bioworks Holdings | 485 |
| 4D Molecular Therapeutics | 196 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| BridgeBio Oncology Therapeutics | 106 |
| Tectonic Therapeutic | 60 |
AGMB News
- 16 days ago - Agomab Therapeutics NV trading resumes - TheFly
- 16 days ago - Agomab Therapeutics NV trading halted, volatility trading pause - TheFly
- 22 days ago - Agomab announces NOV-ERA study design - TheFly
- 22 days ago - Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease - GlobeNewsWire
- 23 days ago - Agomab initiated with a Buy at H.C. Wainwright - TheFly
- 7 weeks ago - Agomab Announces Results of Annual General Meeting - GlobeNewsWire
- 2 months ago - Agomab to Participate in Upcoming Conferences - GlobeNewsWire
- 2 months ago - Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook - GlobeNewsWire